DOCETAXEL Drug Record
-
DOCETAXEL chembl:CHEMBL92 ApprovedAntineoplasticImmunotherapy
Alternate Names:
RP-56976 TAXOTERE DOCETAXEL, ANHYDROUS N-DEBENZOYL-N-(TERT-BUTOXYCARBONYL)-10-DEACETYLTAXOL TXL DOCETAXEL DOCECAD® N-DEBENZOYL-N-(TERT-BUTOXYCARBONYL)-10-DEACETYLPACLITAXEL EMDOC DOCETAXEL ANHYDROUS TAXOTERE® pubchem.compound:148124 drugbank:01248 chemidplus:114977-28-5 chembl:CHEMBL92 rxcui:1299922 Drug Info:
FDA Approval approved Drug Class Small Molecule Drug Indications antineoplastic agent Drug Categories taxane derivatives Drug Categories cyclodecanes Year of Approval 1996 Drug Class antineoplastic agents Pharmaceutical Developer BIND Biosciences Source Reported Drug Name(s) BIND-014/PSMA-targeted docetaxel nanoparticle Drug Class Folate Inhibitor Drug Categories agents causing muscle toxicity Drug Categories cardiotoxic antineoplastic agents Drug Categories cytochrome p-450 cyp3a substrates Drug Categories cytochrome p-450 cyp3a4 inhibitors Drug Categories cytochrome p-450 cyp3a4 inhibitors (strength unknown) Drug Categories cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index Drug Categories cytochrome p-450 cyp3a5 substrates Drug Categories cytochrome p-450 cyp3a5 substrates with a narrow therapeutic index Drug Categories cytochrome p-450 cyp3a7 substrates Drug Categories cytochrome p-450 cyp3a7 substrates with a narrow therapeutic index Drug Categories cytochrome p-450 enzyme inhibitors Drug Categories cytochrome p-450 substrates Drug Categories hepatotoxic agents Drug Categories microtubule inhibition Drug Categories microtubule inhibitors Drug Categories oatp1b3 substrates Drug Categories p-glycoprotein substrates Drug Categories p-glycoprotein substrates with narrow therapeutic index Publications:
-
Interaction Types & Directionality:
n/a Interaction Info:
-
Interaction Types & Directionality:
n/a Interaction Info:
-
Interaction Types & Directionality:
inhibitor (inhibitory) Interaction Info:
Reported Cancer Type Prostate -
Interaction Types & Directionality:
n/a Interaction Info:
-
Interaction Types & Directionality:
n/a Interaction Info:
-
Interaction Types & Directionality:
inhibitor (inhibitory) Interaction Info:
Specific Action of the Ligand Inhibition Endogenous Drug? False Direct Interaction? True
-
Alternate Names:
DOCETAXEL DrugBank Drug Name 114977-28-5 CAS Number Act Docetaxel 40 mg/ml Drug Brand Drug Info:
Drug Type small molecule Drug Groups approved Drug Groups investigational Publications:
-
- Version: 25-July-2013
Alternate Names:
Docetaxel Drug Trade Name Docetaxel Drug Development Name Drug Info:
Drug Class Folate Inhibitor Source Reported Drug Name(s) BIND-014/PSMA-targeted docetaxel nanoparticle Pharmaceutical Developer BIND Biosciences Publications:
-
Alternate Names:
DOCETAXEL Primary Drug Name Drug Info:
Drug Class antineoplastic agents Year of Approval 1996 Publications:
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications antineoplastic agent Drug Class Small Molecule FDA Approval approved Publications:
-
Alternate Names:
C1526 NCI drug code Drug Info:
Publications:
-
Alternate Names:
Drug Info:
Publications:
-
Alternate Names:
Drug Info:
Publications:
-
Alternate Names:
Drug Info:
Publications:
-
Alternate Names:
D0O5WP TTD Drug ID Drug Info:
Publications:
-
- Version: 29-September-2020
Alternate Names:
DOCETAXEL GuideToPharmacology Ligand Name Drug Info:
Publications:
-
- Version: 15-June-2013
Alternate Names:
Drug Info:
Publications:
-
- Version: ChEMBL_27
Alternate Names:
Drug Info:
Publications:
-
Alternate Names:
Drug Info:
Publications:
-
- Version: 26-July-2013
Alternate Names:
Drug Info:
Publications:
-
Alternate Names:
Drug Info:
Publications: